|Day Low/High||0.79 / 0.85|
|52 Wk Low/High||0.60 / 9.37|
This group appears oversold and downgrades of the big cannabis names may trigger a "buy the bad news" reaction.
* I continue to trade opportunistically and unemotionally - with a calculator in one hand and a contrarian viewpoint on the other hand * The overnight +20 futures rise (China trade-related) has been reversed to a gain of only 3 handles by 6: 30 am *...
A market repricing...which are the 'true' growth stocks now?
After a 2018 high, marijuana stocks are gaining popularity again, but which ones are producing the most green for investors? Here are the charts.
Tilray will look to sustain a sanguine sentiment on cannabis stocks on Tuesday.
Aurora is trying to ride the momentum of Aphria's earnings report and jump in front of other potential strong reports.
Yesterday and most of last week I have been expanding my Canopy Growth long investment position (the stock is on my Best Ideas List). CGC (+6%) and the other pot stocks should thrive today after the Aurora Cannabis revised upward guidance (its share...
Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.
Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?
While the cannabis company's stock is sliding on its year-end report, at least one analyst sees a long-term buying opportunity.
Overall, I don't like the action I'm seeing on my screens. I've been a heavy net seller as I cut positions that are showing some relative weakness.
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
I just mentioned one of my partners here at TheStreet, now let's wheel about and mention 'Sarge' Guilfoyle who sat in this very seat yesterday. In the Stocks Under $10 portfolio, he's been the man in charge of the weed stocks positions and he's done...
The pot sector has been weak recently. I own a very small long position in which is -$1 to under $44/share (which was added to my Best Ideas List on January 2, 2019 at $27.75) As I mentioned I wasn't willing to pay up for recently and, in general, ...
Revenue is where it's at for cannabis in 2019.
A huge week is coming up for these well-known stocks.
Short interest is back in the low single digits while Tilray still enjoys one of the smallest floats for a cannabis company.
Apparently, this game is all about growth right now. It certainly is not about margins.
Some momentum movers are becoming extended and have seen profit-taking Monday.
On Wednesday I explained why I would not buy the gap higher in Aurora Cannabis . There is a tendency for traders, in particular, to buy the latest shiny object and to ask questions later; after all the price momentum is a tradeable thing of beauty t...
Assessing Aurora and its peers, strictly on the numbers.
In this day and age, companies must be 'disruptors' or get left in the dust.
Peltz's addition should pacify a persistent critique of the company.